Nearly two-thirds of patients who encountered prior authorization delays, denials or medication restrictions abandoned care rather than continue seeking approval from their health insurer, according to a November 2026 survey commissioned by healthcare technology company Penguin AI.
The findings carry direct implications for group benefits brokers whose employer clients are expanding utilization management as a cost control strategy. While prior authorization is designed to reduce unnecessary claims, the survey data suggests its application may also be preventing necessary treatment - and creating downstream costs that offset or exceed the savings.
The survey covered 500 US adults who had needed prior authorization for themselves or a family member within the previous two years. Among the 273 respondents who experienced a coverage barrier, 62% said they had given up on care because challenging their insurer was not worth the effort.
The consequences extended beyond delayed treatment. Among all respondents, 36% reported paying out of pocket, 32% delayed care and 21% skipped treatment entirely. Another 17% sought care at an emergency department or urgent care facility - a channel that typically costs three to five times more than an office visit for the same condition. Some 13% said their health had deteriorated.
The results also revealed that many disputed decisions were reversible. While 44% of respondents appealed an insurer’s decision, 47% of those who appealed succeeded in having it overturned. Only 24% had their original decision upheld.
“Patients are leaving a process that often rules in their favor,” Penguin AI CEO Fawad Butt said.
For self-funded employers, that gap between appeal success rates and appeal filing rates is a plan design signal. If the authorization criteria are generating large numbers of denials that are subsequently overturned, the criteria may be miscalibrated - denying care that the plan was always intended to cover, adding administrative burden without reducing spend, and potentially pushing affected employees toward emergency care that the plan then funds at a higher cost.
The findings are particularly relevant as employers expand the use of such restrictions. The 2026 KFF Employer Health Benefits Survey found that 10% of large employers had added utilization management requirements, including prior authorization, for some services in response to projected cost increases.
Among employers with at least 200 workers, 7% reported an increase in services requiring prior authorization over the previous year, compared with 2% reporting a decrease. Nearly half of those reporting an increase cited controlling overall plan cost growth as the primary reason.
The financial implications differ across funding arrangements. Self-funded employers bear the underlying cost of covered claims directly and have more direct visibility into whether authorization requirements are reducing unnecessary spend or simply adding friction. Fully insured employers may see the effects of utilization and administrative performance reflected in premiums and renewal pricing rather than individual claim data.
Physicians have reported similar concerns. The American Medical Association’s 2025 physician survey found that 88% believed prior authorization increased overall healthcare utilization, with 73% citing additional office visits and 47% reporting urgent or emergency care visits as consequences. For a self-funded employer, those additional visits are direct plan costs - which means prior authorization that delays necessary care may be generating the kind of spend it was designed to prevent.
Federal regulators have begun tightening requirements for certain health plans. Under Centers for Medicare and Medicaid Services rules, affected payers must generally respond to urgent authorization requests within 72 hours and standard requests within seven calendar days. These requirements primarily cover government-sponsored health programs and do not generally apply to employer-sponsored commercial plans - meaning employer plans currently operate without mandated turnaround standards and have more design flexibility, for better or worse.
Insurers are also adopting automated review systems to streamline authorization decisions, and some employers are exploring AI-assisted prior authorization as a cost management tool. The Penguin AI survey found that 69% of respondents would be more upset if AI had made or recommended a denial, while 49% would support AI-assisted approvals only with human oversight. For employers considering AI-assisted PA, that sentiment gap - acceptable for approvals, strongly resisted for denials - is a practical plan communication and employee relations consideration alongside the clinical and legal ones.
For group benefits brokers advising employers on utilization management strategy, the survey data supports three specific conversations. First, ask whether prior authorization requirements are targeted at high-cost, high-variation services - specialty drugs, elective procedures, advanced imaging - or applied broadly to routine care where the denial-and-appeal cycle adds cost rather than reducing it. Second, ask the plan sponsor or carrier for data on appeal rates and overturn rates: a high overturn rate on a specific service category is evidence that the authorization criteria are miscalibrated. Third, for self-funded employers, check whether the plan is tracking emergency and urgent care utilization for services where prior authorization denials have increased - if patients denied in office are showing up in emergency departments, the plan is absorbing the cost difference.